Article info
PDFReview
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
- Correspondence to Professor Douglas W Henderson, Department of Surgical Pathology, SA Pathology at Flinders Medical Centre, Bedford Park 5042, South Australia; dhenderson{at}internode.on.net; Doug.Henderson{at}health.sa.gov.au
Citation
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
Publication history
- Received March 8, 2013
- Revised June 7, 2013
- Accepted June 8, 2013
- First published June 27, 2013.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions